Aniridia is a devastating ocular disease requiring intensive eye care, social and community support from birth and throughout an individual’s lifetime.

Recent News

© 2019 Aniridia-net.eu – University of Cologne – Webdesign by Effect Group Ltd.

News Old

Successful meeting with wide participation of researchers, ophthalmologist, patient’s representatives and special interest groups in the 1st COST Action CA18116 MC/WG meeting celebrated last week in Paris. Grant execution updates, working group advancements as well as interesting scientific discussions were brought together in this aniridia-focused session funded by the COST program....

Cornea Connect meeting was held at UCL’s Institute of Ophthalmology last May. Among other conditions, aniridia was brought to debate with very insightful talks about therapeutic options, current research and first hand patient's experiences on the impact of the disease. ...

The Network of Excellence in Corneal Regeneration (NExCR) managed by the COST Action BM1302 ended in 2017, serving to bring together researchers and provide new projects ideas ARREST BLINDNESS and ANIRIDIA-NET. Read more at: https://www.eurotimes.org/cornea-research-eu/ ...

For Join our EU network and create linkages to learn, share and stimulate research in the diagnosis and treatment of aniridia. Engage with this elevator-pitch video by ANIRIDIA-NET action Chair: Professor Neil Lagali. https://twitter.com/i/status/1123938415890915329 ...